ICCC - ImmuCell Corporation logo

ImmuCell Corporation

ICCC

ImmuCell Corporation develops and sells animal health products focusing on dairy and beef cattle. Its main offerings include First Defense, a preventive solution for calf scours, and diagnostic tools for mastitis, targeting cattle health and productivity.

⚕️ Healthcare NASDAQ Listed 1987 $ USD
$1,000 invested 30 years ago →$3,941today

Score Overview

1 Year
Score
Net Growth280.73%
Net TrendGrew
Net Income Consistency—
Rev Growth20.13%
Rev TrendGrew
Revenue Consistency—
5 Years
Score6.7
Net Growth26x
Net Trend60%
Net Income Consistency—
Rev Growth72.58%
Rev Trend60%
Revenue Consistency—
10 Years
Score
Net Growth269.68%
Net Trend60%
Net Income Consistency
Rev Growth247.96%
Rev Trend80%
Revenue Consistency
20 Years
Score4.8
Net Growth190.45%
Net Trend55%
Net Income Consistency
Rev Growth6x
Rev Trend70%
Revenue Consistency
30 Years
Score
Net Growth20x
Net Trend53%
Net Income Consistency
Rev Growth7x
Rev Trend67%
Revenue Consistency
All Time
Score
Net Growth287.96%
Net Trend55%
Net Income Consistency
Rev Growth11x
Rev Trend68%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where ImmuCell Corporation has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • ICCC

2000: 79.9% · 2021: 60.9% · free through 2021 · longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 11.33—
1 Year2025-11-17
$ 4.91130.75%
5 Years2021-11-17
$ 9.0625.00%
10 Years2016-11-17
$ 5.06123.91%
20 Years2006-11-17
$ 5.35111.78%
30 Years1996-11-15
$ 2.88294.09%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 33M$ 1M$ 7M
2025$ 27M-$ 1M$ 3M
2024$ 26M-$ 2M$ 3M
2023$ 17M-$ 5M$ 978.74K
2022$ 18M-$ 2M$ 5M
2021$ 19M-$ 78.29K$ 10M
2020$ 15M-$ 1M$ 7M
2019$ 13M-$ 1M$ 8M
2018$ 10M-$ 2M$ 2M
2017$ 10M-$ 168K$ 3M
2016$ 9M$ 508.45K$ 10M
2015$ 10M$ 1M$ 6M
2014$ 7M-$ 167.16K$ 3M
2013$ 6M$ 117.39K$ 5M
2012$ 5M$ 89.51K$ 4M
2011$ 5M-$ 409.51K$ 4M
2010$ 4M-$ 384.68K$ 4M
2009$ 4M-$ 216.49K$ 4M
2008$ 4M-$ 468.56K$ 5M
2007$ 6M$ 662.14K$ 5M
2006$ 4M$ 647.14K$ 6M
2005$ 4M$ 707.78K$ 5M
2004$ 3M$ 143.52K$ 4M
2003$ 3M$ 411.22K$ 4M
2002$ 6M$ 886.24K$ 3M
2001$ 6M$ 420K$ 1M
2000$ 5M$ 2M$ 1M
1999$ 4M$ 550.84K$ 1M
1998$ 4M-$ 100K$ 1M
1997$ 4M$ 300K$ 1M
1996$ 4M-$ 100K$ 1M
1995$ 4M$ 1M
1994$ 4M-$ 100K$ 1M
1993$ 3M$ 1M
1992$ 3M-$ 200K$ 1M
1991$ 2M-$ 1M$ 800K
1990$ 3M-$ 600K$ 900K
1989$ 2M-$ 1M$ 600K
ICCC - ImmuCell Corporation logo

ImmuCell Corporation fundamental performance

Between 2020 and 2025, revenue grew from $ 15M to $ 27M and net income went from -$ 1M to -$ 1M. Revenue increased in 3 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 10M to $ 27M and net income went from $ 1M to -$ 1M. Revenue increased in 8 of those 10 years; net income in 6.

ImmuCell Corporation currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Membership

Continue ICCC’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,188 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies